Bpifrance
VC Fund
Maisons-alfort, France
Bpifrance is a VC fund in Maisons-alfort focused on Software and Information Technology. Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.
- Total investments:
- 1471
- Last investment:
- Lead investor:
- 26%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Bpifrance invests in
Stages Bpifrance invests in
Countries Bpifrance invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $757k–$6.3M
- Series A
- $3M–$34M
Investment Focus
Industry
- Software 156 (11%)
- Information Technology 102 (7%)
- Health Care 94 (6%)
- Biotechnology 89 (6%)
- Manufacturing 74 (5%)
Stage
- Seed 254 (17%)
- Funding Round 223 (15%)
- Series A 133 (9%)
- Series B 81 (6%)
- Pre-Seed 42 (3%)
Country
- France 744 (51%)
- United States 25 (2%)
- Switzerland 4 (0%)
- Brazil 2 (0%)
- Canada 2 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Adrien Neel
Investment Director
|
Investment Director | Total investments: 2 | Find email | |
Cédric Clement
Senior Investment Director | Bpifrance Deeptech Venture
|
Senior Investment Director | Bpifrance Deeptech Venture | Total investments: 1 | Find email | |
Charlotte Corbaz
Investment Drector - Large Venture
|
Investment Drector - Large Venture | Total investments: 3 | Find email | |
Clarisse Blandin
Investment director
|
Investment director | Total investments: 2 | Find email | |
|
Laure Michel
Investment Director
|
Investment Director | Total investments: 5 | Find email | |
| See all 32 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Apolownia
|
Apolownia operates an integrated development platform that designs, implements, and monitors high-integrity coastal ecosystem restoration and blue carbon projects. The company centralizes the entire project chain from site identification and feasibility to remote sensing and long-term verification to provide transparent, measurable carbonsequestration solutions. Its value proposition lies in helping corporate clients and investment funds fulfill stringent climate targets through premium verified carbon credits that demonstrate a clear, durable impact on biodiversity and local communities. | $1.2M / Seed / Jul 31, 2026 | |
Ascendance
|
Founded in 2018 by four ex-Airbus engineers: Jean-Christophe Lambert, Thibault Baldivia, Clément Dinel and Benoît Ferran, Ascendance is an industrial start-up with a mission to decarbonise aviation. Based in the heart of Toulouse, the European capital of aviation, it has developed and markets two products: an innovative hybrid-electric propulsionsystem ‘Sterna’, and a hybrid-electic vertical take-off and landing (VTOL) aircraft powered by Sterna technology, ‘Atea’. | $15.9M / Series B / Jul 27, 2026 | |
Brenus Pharma
|
Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment. | $12.6M / Series A / Jul 20, 2026 | |
ENGO Eyewear
|
ENGO Eyewear is a specialist tech company that designs and builds high performance smart glasses tailored specifically for endurance athletes like runners, cyclists, and triathletes. | $5.8M / Seed / Jul 17, 2026 | |
Syntetica
|
Syntetica is a materials technology and climate technology company that develops chemical recycling technology for synthetic textiles. It uses proprietary green chemistry to convert nylon textile waste into virgin-quality recycled polymers, enabling circular production for the textile, automotive, and industrial materials industries. Its mission isto decarbonize synthetic materials by making high-quality recycled feedstocks commercially viable.The company's proprietary chemical depolymerization process separates and recovers Nylon 6 and Nylon 6,6 from blended textile waste that would otherwise be difficult to recycle. The process operates under low-temperature, low-pressure conditions, removes dyes and finishes, and produces recycled raw materials that can be reintroduced into manufacturing without compromising quality. Syntetica's technology supports textile-to-textile recycling and is designed to reduce carbon emissions, landfill waste, and reliance on virgin fossil-based materials. | $30M / Series A / Jul 16, 2026 | |
Stracker
|
STRACKER offers a digital platform for commission-free global freight forwarding. | $2.9M / Seed / Jul 15, 2026 | |
En Carta Diagnostics
|
En Carta Diagnostics develops molecular diagnostic technologies that enable the rapid detection of DNA and RNA pathogens at the point of care. The company designs programmable diagnostic platforms that deliver laboratory-grade molecular testing without requiring specialized equipment or extensive technical training. Its technology uses syntheticbiology and portable diagnostic devices to support the detection of infectious diseases, including Lyme disease, as well as other bacterial and viral pathogens. En Carta Diagnostics also develops custom molecular diagnostic solutions and expands its platform to address a broad range of genetic and infectious disease applications. The company collaborates with research institutions and applies its proprietary diagnostic technology to improve the accessibility and reliability of molecular testing across healthcare settings. | $2.3M / Grant / Jul 10, 2026 | |
Cyllene Therapeutics
|
EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy. | $37.7M / Series C / Jul 07, 2026 | |
Elixir Aircraft
|
Elixir Aircraft is an aerospace company that provides aircraft, component manufacturing, and training services. | $51.4M / Venture - Series Unknown / Jul 02, 2026 | |
Beams
|
Beams is a producer of medical devices for cancerology based on the use of particles β. | $1.7M / Seed / Jun 26, 2026 | |
| See all 1471 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Bpifrance invest in?
Bpifrance invests primarily in Software, Information Technology and Health Care startups, most often at Seed and Funding Round stage. Most of the 1,471 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Bpifrance's check size?
Bpifrance typically joins rounds of $757k–$6.3M at Seed and $3M–$34M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Bpifrance participates in.
How do I contact Bpifrance?
Public channels for Bpifrance include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Bpifrance?
The team at Bpifrance includes Adrien Neel (Investment Director), Cédric Clement (Senior Investment Director | Bpifrance Deeptech Venture) and Charlotte Corbaz (Investment Drector - Large Venture), among 32 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
